Thymosin Alpha 1: Reduces the mortality of severe COVID-19 by the restoration of lymphocytopenia and reversion of exhausted T-cells.
Thymosin Alpha 1: Reduces the mortality of severe COVID-19 by the restoration of lymphocytopenia and reversion of exhausted T-cells.